Introduction
Hematopoiesis in vertebrate occurs in two waves, primitive and definitive. [1] [2] [3] In mouse, primitive or embryonic wave of hematopoiesis occurs around embryonic day 7.5 in the yolk sac blood island, and produces primitive erythrocytes and macrophages. 4, 5 This primitive wave hematopoiesis lasts for a transient period of a few days and is subsequently replaced by the definitive program. Murine definitive hematopoiesis is believed to originate from a distinctive region known as the aortagonad-mesonephros at embryonic days 7.5-8. 6, 7 These definitive hematopoietic precursors, presumably the definitive hematopoietic stem cells, then migrate to the fetal liver where they undergo rapid proliferation and differentiation, and finally colonize the bone marrow for adult hematopoiesis. In contrast to primitive hematopoiesis, the definitive hematopoietic program gives rise to all the mature blood cell types and remains active throughout the lifetime of the organism.
In zebrafish, hematopoiesis also comprises both primitive and definitive programs and produces mature blood cell types similar to those found in mammals. 8, 9 Zebrafish primitive erythropoiesis begins at the 4-somite stage as a pair of bilateral stripes in the posterior lateral mesoderm. 10 These stripes extend anteriorly and posteriorly, and then converge in the midline at the 20-somite stage to form the intermediate cell mass (ICM), where erythroid precursors further develop and enter the circulation by 24-26 hours postfertilization (hpf). 10, 11 On the other hand, primitive myelopoiesis originates from the rostral blood island in the anterior lateral mesoderm at around the 10-somite stage and produces mainly macrophages and possibly some neutrophils. [12] [13] [14] [15] Recent studies demonstrate that zebrafish definitive hematopoiesis
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The zebrafish mutant, ugly duckling (udu tu24 ), was first isolated from the 1996
Tuebingen large scale screen as a mutant defective in morphogenesis during gastrulation and tail formation. 18 In this article, we report the isolation and detailed study of a new udu allele, udu sq1 , as a mutant with defect in blood cell development. 
Materials and Methods

Fish maintenance and genetic screen
Zebrafish were maintained at 27 to 28°C as described at http://zfin.org. Mutagenesis was performed as described previously using ethylnitrosourea (ENU) (Sigma) as a mutagen 19, 20 and udu sq1 mutant was isolated based on defect in blood circulation in F3.
WISH
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TUNEL assay
Embryos were fixed in 4% paraformaldehyde (Fluka, USA) and dehydrated in PBST/methanol series (50%, 70%, 95%, and 100%), followed by incubation in 100% acetone at -20ºC (10min) and rinses in PBST. The fixed embryos were then permeabilized in fresh 0.1% sodium citrate in PBST (15min) and followed by proteinase K treatment (10µg/ml, 20min). The embryos were fixed again in 4% PFA followed by PBST rinses and finally assayed using In Situ Cell Death Detection Kit, Fluorescein (Roche) according manufacture's protocol.
FACS, cytology, and cell cycle analysis
24hpf udu sq1-/-and sibling embryos (300-400/pool) obtained from crossing adult udu sq1+/-/Tg(-5.0scl:EGFP) with udu sq1+/-fish were separated based on the morphological phenotype and disaggregated in cold 0.9X PBS with 5% FBS (Hyclone, USA). The cell suspensions were passed through a 70µm-pore size filter and spun at 1000rpm for 5min. The pellets were re-suspended in 1ml Cell Dissociation BufferFree Hanks (Gibco, USA) and incubated at 37°C for 20min. After addition of 1ml washing buffer {Hanks buffered saline solution containing 20% calf serum, 5mM
CaCl 2 and DNase (50µg/ml)}, the cell suspensions were spun at 1000rpm for 5min
and re-suspended in PBS. After passing through a 40µm-pore size filter, cells (10 6 /ml)
were analysed by FACS analysis (Beckton Dickinson, USA). 
Positional cloning
Single embryo genomic DNA was prepared by incubating a single embryo in 50µl 1X
TE buffer (pH8.0) with 0.5mg/ml proteinase K (Finnzymes, Finland) at 55°C overnight. After incubation at 98°C for 10min, 1µl of each sample was used as template for each PCR reaction.
Initial mapping was done by the bulk segregation analysis as described 
Morpholino (MO) knockdown
The udu MOs (Gene Tools, USA), MO-udu-1 (5'-TAACACTACACTCACCACCC CTTTT-3') and MO-udu-2 (5'-AAAAGGCTTGCTGACCGTCGTTGTC-3'), are designed to specifically block RNA splicing of the udu gene, whereas the p53 MO 
Affymetrix array analysis
Total RNA was extracted from 1dpf udu sq1-/-and sibling embryos using TRIzol (Gibco-BRL, USA), treated with DNase I and purified using RNeasy Mini kit (QIAgen, Germany). Hybridization was performed according to the manufacturer's instruction (Affymetrix, USA). Data were analyzed using Microarray Suite 5.0 software (Affymetrix, USA).
Semi-quantitative and real-time RT-PCR
Total RNA of embryos, extracted as previously described, was reversely transcribed using SuperScript™ III RNase H Reverse Transcriptase (Invitrogen, USA). The amount of reversely transcribed cDNAs was normalized with the Real-time
LightCycler (Roche, Germany) using elongation factor 1 alpha (elf1α) as a reference.
Semi-quantitative RT-PCR was performed for either 25 or 30 cycles at 94°C for 30sec; 58°C for 10sec; 72°C for 30sec. For real-time RT-PCR, total RNA of GFP+ cells sorted from 24hpf udu sq1-/-and wild type sibling embryos was extracted using RNeasy
Micro kit (QIAgen, Germany). Reverse transcription was performed using Superscript III Kit (Invitrogen), about 10% of the RT products were amplified in the real-time PCR reaction using the LightCycler System (Roche) according to the manufacturer's instruction. elf1α was used as an internal reference to normalize the PCR reaction.
Primer sequences are listed as follows:
Results
Primitive Erythrocyte Hypoplasia in udu sq1-/-Mutant
To study the genetic programs governing vertebrate hematopoiesis, we carried out a forward genetic screen in search of zebrafish mutants affecting hematopoiesis.
Among the hematopoiesis-defective mutants recovered, wz260 exhibited morphological phenotype similar to that of zebrafish mutant ugly duckling (udu tu24 )
isolated from the 1996 Tuebingen screen. 18 Complementation analysis confirmed that wz260 was a new allele of udu tu24 , thus this mutant was re-named as udu sq1 . As both udu alleles displayed similar phenotype, we used udu sq1 for detailed analysis in this study. The zebrafish udu sq1-/-embryos began to show notable morphological abnormality at around 24hpf such as short body axis, bent-down tail, irregular somites, small head and eyes and lack of blood circulation, and could not survive beyond 7-10dpf (data not shown). 18 In this report, we focused our study on the primitive erythroid defect of udu sq1
. We first performed o-dianisidine staining to examine primitive erythropoiesis and found that hemoglobin level was severely reduced in the 2dpf udu sq1-/-mutant ( Figure 1M-N) . To explore the erythroid defects in depth, we examined the expression of two critical early hematopoietic markers lmo2 and scl. Figure 2C ). In contrast, the udu sq1-/-mutant GFP+ cells, which
were mainly erythroid cells, were much larger in cell size and lacked chromatin condensation ( Figure 2F ). Although these features resembled those erythroid progenitors found in the 16hpf wild type embryos (data not shown), the mutant GFP+ cells also displayed nuclear-cytoplasm asynchrony, which is a characteristic of abnormal megaloblastic erythroid cells found in human megaloblastic anemia patients. 27 Taken together, these data demonstrate that the udu sq1-/-primitive erythroid cells are defective in cell proliferation and differentiation abilities.
Identification of the udu sq1 Gene
Positional cloning revealed that the predicted Ensemble gene ENSDARG00000005867 was the candidate for the udu sq1 mutant gene ( Figure 3A ).
5' and 3' RACE revealed that the full-length cDNA sequence of ENSDARG00000005867 were 6787 base pairs encoding a novel protein of 2055aa
( Figure 3B ; Figure S2 ). Through sequencing, the mutations in udu tu24 and udu sq1 mutants were discovered at exon 12 (T1461 to A) and exon 21 (T2976 to A)
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To confirm that the udu sq1-/-mutant phenotype is indeed caused by mutation in the ENSDARG00000005867 gene, we first performed a rescue experiment with in vitro synthesized ENSDARG00000005867 RNA. Primitive erythropoiesis was restored in 59 out of the 64 (92%) udu sq1-/-embryos injected with wild type RNA (udu-wt) ( Figure 3E ; Table S1 ). In contrast, injecting the udu sq1 mutant RNA (udu-T2976A) bearing a single point nonsense mutation (nucleotide T2976 changes to A) failed to do so ( Figure 3F ; Table S1 ). As expected, embryos injected with two udu MOs, MOudu-1 (data not shown) and MO-udu-2, displayed a phenotype mimicking the udu sq1-/-mutant ( Figure 3G -3J and Table S2 ). These data demonstrate that the loss-of-function mutation in the ENSDARG00000005867 gene indeed causes the udu sq1-/-mutant phenotype. We herein refer ENSDARG00000005867 gene as the udu gene.
Cell autonomous Erythroid Defect in udu sq1-/-Mutant
WISH showed that the udu transcript was detected as early as one-cell stage in wild type zebrafish embryos ( Figure 4A ). The maternal udu mRNA retained robust expression during blastula and diminished at the onset of gastrulation (~6hpf) ( Figure   4B -D). Around the time when segmentation began, the udu transcript, presumably the zygotic mRNA, began to re-appear in a ubiquitous manner, and was subsequently enriched in the CNS as well as the ICM from the 18-somite stage onwards ( Figure   4E -H). At 24hpf udu mRNA was also detected in the anterior parts of kidney ducts ( Figure 4I ).
From the temporal and spatial expression of the udu gene, we believe that Udu possibly plays a cell-autonomous role during the primitive red blood cell development.
To investigate this speculation, we performed a transplantation experiment. Around indicates that the udu gene acts cell-autonomously to affect primitive red blood cell development. However, non-cell autonomous effect cannot be excluded.
udu Gene Encodes a Putative Transcriptional Modulator
Blast searches in database revealed that the Udu protein had the highest homology to the human and mouse GON4L in both protein sequence and gene structure ( Figure S2 ). 28 Sequence alignment reveals that there are several highly conserved regions ( Figure 5A and Figure S2 ). The first three conserved regions (CR-1, CR-2 and CR-3) share no obvious similarity to any of the known domains. The fourth and fifth (from aa 1538 to 1740), which are predicted to consist of four α -helixes each, are similar to the PAH repeats found in SIN3 proteins, 29, 30 and are thus designated as PAH-like (PAH-L) 1 and 2 domain ( Figure 5A ). Finally, the solution structure (IUG2_A) of the last conserved region (aa 1947 to aa 2039) has been solved in the For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From mouse udu homologue GON4L (www.ebi.ac.uk/thornton-srv/databases/cgibin/pdbsum/GetPage.pl?pdbcode=1ug2). The structure analysis reveals that this last conserved region resembles the SANT domain found in several chromatin-remodeling molecules ( Figure 5A-B) , 31 suggesting that the Udu protein may be involved in transcription regulation.
To provide additional evidence to support this argument, we carried out rescue experiment with the truncated udu-∆SANT-L RNA, in which three α -helixes (from aa 1963 to 2031) of the SANT-L domain of the Udu protein were deleted. As shown in Figure 5 , the red blood cell development was restored in the mutant embryos injected with the udu-wt RNA ( Figure 5E ). However, the truncated udu-∆SANT-L RNA failed to do so ( Figure 5F ; Table S1 ), demonstrating that the SANT-L domain is critical for the function of the Udu protein. In addition, udu cDNA (pcDNA3.1/udu-wt) was transfected into COS7 cells to examine the sub-cellular localization of the Udu protein.
Immunohistochemistry analysis showed that the Udu protein was predominantly localized in the nucleus ( Figure 5G-I ). These data strongly suggest that the Udu protein may function as a transcription regulator important for erythroid cell development.
Elevation of p53 Activity Partially Contributes to the Erythroid Defect in udu sq1-/-
Mutant
Microarray analysis was performed to identify potential target genes perturbed in udu sq1-/-mutant. Results from two sets of independent experiments showed that expression of 87 and 57 genes were down-and up-regulated respectively, with 2-fold and above differences in the udu sq1-/-mutant embryos (Table S3 and S4) . As expected, most of the down-regulated genes are related to either hematopoiesis or neurogenesis.
For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From Notably, several up-regulated genes including p53, fos, mdm2, gadd45αl, caspase 8, and tdag51, are known to be involved in cell cycle control and apoptosis [32] [33] [34] [35] (Table   S4 ; Figure S3 ). Considering the G2/M cell cycle arrest of the udu sq1-/-erythroid cells, we focused on p53 and its downstream target gadd45αl. WISH showed that in the 24hpf udu sq1-/-embryos, the RNA levels of p53 ( Figure 6A-B) and gadd45αl ( Figure   6I -J) were significantly elevated in the CNS and ICM regions. To confirm that p53 transcript was indeed up-regulated in udu sq1-/-mutant erythroid cells, real time RT-PCR was performed using GFP+ cells sorted from 24hpf wild type or udu sq1-/-mutant embryos. As shown in Table 2 Table S1 ). As anticipated, elevated gadd45αl expression was no longer detected in these p53 morphant mutants ( Figure 6I-K) . Taken together, these data suggest that up-regulation of p53 activity contributes, at least partially, to the erythroid cell hypoplasia in udu sq1-/-mutant.
Discussion
In this article, we have shown that the udu gene, which encodes a novel nuclear protein containing two PAH-L repeats and a SANT-L domain, plays a critical role in regulating primitive erythroid lineage cell cycle progression and differentiation.
This was indicated by the lack of erythroid specific marker band3 expression and the accumulation of G2/M phase in erythroid cells in udu sq1-/-embryos. We noticed that, although expressed ubiquitously throughout early development, the udu gene appears to be dispensable for early embryogenesis as well as initiation of primitive 29 is distantly related to the helix-loop-helix motif and has been shown to mediate protein-protein interaction. 30 The yeast SIN3 protein and its related mammalian homologues, Sin3A
and Sin3B, interact through the PAH domain, with numerous sequence-specific transcription factors and recruit histone deacetylases to suppress downstream target gene transcription. 37 This implies that Udu protein may form complexes with interaction partners via PAH domain. The SANT and Myb-DNA binding (Myb-DB)
domains have a similar overall structure but confer distinct functions. 38 The Myb-DB domain usually contains two to three tandem repeats and recognizes specific DNA sequence, whereas the SANT domain consists of one to two repeats and plays an important role in chromatin remodeling. 38 Considering the fact that the Udu protein contains only one repeat of this domain that lacks positive electrostatic surface patch as predicted by structural modeling analysis, we believe that this conserved region resembles the SANT domain. As the Udu protein has both PAH-L and SANT-L domains, it is possible that Udu may function as a chromatin-remodeling molecule involved in transcription regulation of many target genes. Further experiments need to be performed to support our hypothesis.
p53 is well recognized as one of the most important tumor suppressors in preventing cancer by modulating downstream target gene expression in response to various cell stresses, such as DNA damage and oncogene activation, resulting in cell cycle arrest or death of abnormal cells. 32, 33 Over-expression of p53 during embryogenesis causes various developmental defects in mouse, fly and worm. [39] [40] [41] [42] More recently, the developmental defects caused by loss-of-function mutations in zebrafish DNA polymerase delta1 or def gene have been shown to be associated with increased p53 activity. 43, 44 These observations imply that p53 plays an important role in maintaining normal cell growth and differentiation during animal development. It has been recently shown that a new gene next to the human GON4L, the human counterpart of udu, is generated as a result of segmental duplication on human chromosome 1q22. 28 Surprisingly, this segmental duplication does not exist in rat, mouse, chicken and zebrafish, suggesting that this duplication may be associated with 
